BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 37188495)

  • 1. A Point Mutation at C151 of
    Gatbonton-Schwager T; Yagishita Y; Joshi T; Wakabayashi N; Srinivasan H; Suzuki T; Yamamoto M; Kensler TW
    Mol Pharmacol; 2023 Aug; 104(2):51-61. PubMed ID: 37188495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and quantification of the basal and inducible Nrf2-dependent proteomes in mouse liver: biochemical, pharmacological and toxicological implications.
    Walsh J; Jenkins RE; Wong M; Olayanju A; Powell H; Copple I; O'Neill PM; Goldring CE; Kitteringham NR; Park BK
    J Proteomics; 2014 Aug; 108(100):171-87. PubMed ID: 24859727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the multiple sensor mechanism of the Keap1-Nrf2 system.
    Takaya K; Suzuki T; Motohashi H; Onodera K; Satomi S; Kensler TW; Yamamoto M
    Free Radic Biol Med; 2012 Aug; 53(4):817-27. PubMed ID: 22732183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice.
    Yates MS; Tran QT; Dolan PM; Osburn WO; Shin S; McCulloch CC; Silkworth JB; Taguchi K; Yamamoto M; Williams CR; Liby KT; Sporn MB; Sutter TR; Kensler TW
    Carcinogenesis; 2009 Jun; 30(6):1024-31. PubMed ID: 19386581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic or pharmacologic amplification of nrf2 signaling inhibits acute inflammatory liver injury in mice.
    Osburn WO; Yates MS; Dolan PD; Chen S; Liby KT; Sporn MB; Taguchi K; Yamamoto M; Kensler TW
    Toxicol Sci; 2008 Jul; 104(1):218-27. PubMed ID: 18417483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDDO-Im protects from acetaminophen hepatotoxicity through induction of Nrf2-dependent genes.
    Reisman SA; Buckley DB; Tanaka Y; Klaassen CD
    Toxicol Appl Pharmacol; 2009 Apr; 236(1):109-14. PubMed ID: 19371629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bardoxolone methyl inhibits the infection of rabies virus via Nrf2 pathway activation in vitro.
    Chi YL; Xie Y; Liu SQ; Zhu WY
    Virol J; 2023 Nov; 20(1):258. PubMed ID: 37950261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics of Chemically Distinct Classes of Keap1-Nrf2 Activators Identify Common and Unique Gene, Protein, and Pathway Responses In Vivo.
    Wible RS; Tran QT; Fathima S; Sutter CH; Kensler TW; Sutter TR
    Mol Pharmacol; 2018 Apr; 93(4):297-308. PubMed ID: 29367259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis.
    To C; Ringelberg CS; Royce DB; Williams CR; Risingsong R; Sporn MB; Liby KT
    Carcinogenesis; 2015 Jul; 36(7):769-81. PubMed ID: 25939751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C151 in KEAP1 is the main cysteine sensor for the cyanoenone class of NRF2 activators, irrespective of molecular size or shape.
    Dayalan Naidu S; Muramatsu A; Saito R; Asami S; Honda T; Hosoya T; Itoh K; Yamamoto M; Suzuki T; Dinkova-Kostova AT
    Sci Rep; 2018 May; 8(1):8037. PubMed ID: 29795117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties.
    Wang YY; Yang YX; Zhe H; He ZX; Zhou SF
    Drug Des Devel Ther; 2014; 8():2075-88. PubMed ID: 25364233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation.
    Song MK; Lee JH; Ryoo IG; Lee SH; Ku SK; Kwak MK
    Free Radic Biol Med; 2019 Jul; 138():33-42. PubMed ID: 31059771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against phalloidin-induced liver injury by oleanolic acid involves Nrf2 activation and suppression of Oatp1b2.
    Lu YF; Liu J; Wu KC; Klaassen CD
    Toxicol Lett; 2015 Jan; 232(1):326-32. PubMed ID: 25280775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synthetic triterpenoids CDDO-TFEA and CDDO-Me, but not CDDO, promote nuclear exclusion of BACH1 impairing its activity.
    Casares L; Moreno R; Ali KX; Higgins M; Dayalan Naidu S; Neill G; Cassin L; Kiib AE; Svenningsen EB; Minassi A; Honda T; Poulsen TB; Wiel C; Sayin VI; Dinkova-Kostova AT; Olagnier D; de la Vega L
    Redox Biol; 2022 May; 51():102291. PubMed ID: 35313207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological activity evaluation of a series of bardoxolone methyl prodrugs.
    Liu L; Pan X; Xie F; Xu X; Xiao D; Xiao J; Zhou X
    Bioorg Chem; 2022 Jul; 124():105831. PubMed ID: 35512420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic triterpenoids attenuate cytotoxic retinal injury: cross-talk between Nrf2 and PI3K/AKT signaling through inhibition of the lipid phosphatase PTEN.
    Pitha-Rowe I; Liby K; Royce D; Sporn M
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5339-47. PubMed ID: 19494206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keap1-Nrf2 signaling activation by Bardoxolone-methyl ameliorates high glucose-induced oxidative injury in human umbilical vein endothelial cells.
    Yang JL; Sun MY; Yuan Q; Tang S; Dong MJ; Zhang RD; Liu YY; Mao L
    Aging (Albany NY); 2020 Jun; 12(11):10370-10380. PubMed ID: 32484788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity.
    Yamamoto T; Suzuki T; Kobayashi A; Wakabayashi J; Maher J; Motohashi H; Yamamoto M
    Mol Cell Biol; 2008 Apr; 28(8):2758-70. PubMed ID: 18268004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withaferin A induces Nrf2-dependent protection against liver injury: Role of Keap1-independent mechanisms.
    Palliyaguru DL; Chartoumpekis DV; Wakabayashi N; Skoko JJ; Yagishita Y; Singh SV; Kensler TW
    Free Radic Biol Med; 2016 Dec; 101():116-128. PubMed ID: 27717869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes.
    Yates MS; Tauchi M; Katsuoka F; Flanders KC; Liby KT; Honda T; Gribble GW; Johnson DA; Johnson JA; Burton NC; Guilarte TR; Yamamoto M; Sporn MB; Kensler TW
    Mol Cancer Ther; 2007 Jan; 6(1):154-62. PubMed ID: 17237276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.